Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
ATNM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.35%62.981.0%$459.39m
AMGNAmgen, Inc. 0.41%241.491.3%$450.37m
BIIBBiogen, Inc. -0.22%285.501.4%$388.18m
ILMNIllumina, Inc. -0.38%324.723.5%$319.30m
VRTXVertex Pharmaceuticals, Inc. 0.14%235.831.9%$300.51m
REGNRegeneron Pharmaceuticals, Inc. 0.10%385.942.6%$230.09m
EXASEXACT Sciences Corp. -1.92%88.0624.0%$200.47m
ALXNAlexion Pharmaceuticals, Inc. 0.68%113.272.0%$195.19m
ITCIIntra-Cellular Therapies, Inc. -1.43%26.259.0%$173.29m
INCYIncyte Corp. -0.15%80.502.5%$149.14m
SRPTSarepta Therapeutics, Inc. -1.84%127.9014.6%$142.47m
ARWRArrowhead Pharmaceuticals, Inc. -1.21%56.4211.4%$131.86m
SGENSeattle Genetics, Inc. 1.25%109.006.1%$126.99m
BMRNBioMarin Pharmaceutical, Inc. -0.97%88.274.3%$108.23m
AAgilent Technologies, Inc. 0.79%90.171.6%$106.55m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.